Skip to content

HYPOCAL-PHARMA

Inactive
KBO/BCE: BE 0478.068.062

HYPOCAL-PHARMA was declared bankrupt on 02-12-2013 (Rechtbank van koophandel te Dendermonde). The bankruptcy was closed by liquidation by judgment of 27-10-2016, published in the Belgian Official Gazette on 07-11-2016.

Summary

Inactive. The last annual accounts are for financial year 2012.

HYPOCAL-PHARMAInactive

Overview

Official details

Source: KBO
Status
Inactive deed of incorporation of 07-08-2002 · bankruptcy closed on 27-10-2016
Activity
No activity registered in the KBO
Financial year end
31 December
Peppol
Not found in the Peppol Directory

Financial position

No score
Annual accounts 2012
Gross margin
€254,849
▼ 52.7%
Turnover
≈ €600,000
estimated
Loss
€135,646
Equity
€44,571
Total assets
€1.0m
▼ 4.7%
Staff
7.7 FTE
▼ 9.4%

Key points

  • Caution: From profit to loss in 2012after a profit of €16,546 in 2011 -€135,646 View

Recent changes

  1. · Bankruptcy Bankruptcy closure (by liquidation)Commercial Court of Ghent, Dendermonde division · judgment of 27-10-2016
  2. · Bankruptcy Bankruptcy declaredRechtbank van koophandel te Dendermonde · judgment of 02-12-2013
  3. · Gazette deed Incorporation16 publications in the Belgian Official Gazette, the last on 10-12-2013
All 14 events

Key facts about HYPOCAL-PHARMA

What is the company number of HYPOCAL-PHARMA?
The company number of HYPOCAL-PHARMA is 0478.068.062. The VAT number is the same number with BE in front: BE 0478.068.062.
What is the legal form of HYPOCAL-PHARMA?
The legal form of HYPOCAL-PHARMA is NV.
Is HYPOCAL-PHARMA still active?
No. HYPOCAL-PHARMA is inactive in the KBO register.Company details
How many employees did HYPOCAL-PHARMA have?
HYPOCAL-PHARMA had an average of 7.7 full-time equivalents in financial year 2012, according to the filed annual accounts.Financials
What is the turnover of HYPOCAL-PHARMA?
The turnover in financial year 2012 is ≈ €600,000. This figure is estimated from the gross margin of €254,849 and 2,281 comparable companies of the same size. It probably lies between €360,000 and €1.0m. It is a rough estimate.
Is HYPOCAL-PHARMA profitable?
In financial year 2012, HYPOCAL-PHARMA made a loss of €135,646.
Where can I find the annual accounts of HYPOCAL-PHARMA?
HYPOCAL-PHARMA filed 9 annual accounts with the National Bank of Belgium, the latest for financial year 2012.